您的位置:易推广 > 生物试剂/抗体/细胞 > 生物制剂 > 克隆系统 > 上海凯博生物科技有限公司(武汉分公司) > 产品展示 > 抗体 > 国产抗体 > DMTF1周期素D相互作用蛋白1抗体

产品展示

DMTF1周期素D相互作用蛋白1抗体

点击次数:288发布时间:2012/12/5 13:54:13

DMTF1周期素D相互作用蛋白1抗体

更新日期:2024/9/5 14:43:01

所 在 地:中国大陆

产品型号:BY-6891R

简单介绍:本公司经销DMTF1,周期素D相互作用蛋白1抗体,克隆类型为polyclonal,宿主来源是Rabbit,DMTF1周期素D相互作用蛋白1抗体可应用于WB、elisa、IP、IF、IHC等实验,欢迎垂询订购!

优质供应

详细内容

本公司经销DMTF1,周期素D相互作用蛋白1抗体,克隆类型为polyclonal,宿主来源是Rabbit,DMTF1周期素D相互作用蛋白1抗体可应用于WB、elisa、IP、IF、IHC等实验,欢迎垂询订购!

货号:BY-6891R
英文名称:Anti-DMTF1
中文名称:周期素D相互作用蛋白1抗体
其他名称:名Cyclin D binding Myb like transcription factor 1;cyclin D binding myb like transcription factor 1D interacting myb like protein;Cyclin D interacting Myb like protein 1;Cyclin-D-binding Myb-like transcription factor 1;Cyclin-D-interacting Myb-like protein 1;D interacting myb like protein;DMP1;DMTF;dmtf1;DMTF1_HUMAN;hDMP1;hDMTF1;mDmp1.
抗体来源:Rabbit
克隆类型:polyclonal
蛋白分子量:predicted molecular weight: 84kDa
纯化方法:affinity purified by Protein A
交叉反应:hu, mo, rat, chk, cow, dog
产品介绍:Transcriptional activator which activates the CDKN2A/ARF locus in response to Ras-Raf signaling, thereby promoting p53/TP53-dependent growth arrest. Binds to the consensus sequence 5'-CCCG[GT]ATGT-3'. Isoform 1 may cooperate with MYB to activate transcription of the ANPEP gene. Isoform 2 may antagonize transcriptional activation by isoform 1.Tissue Specificity : Expressed at relatively low levels in colonic mucosa, ovary, peripheral leukocytes, prostate and small intestine, and at higher levels in spleen, testis and thymus. Expressed in multiple regions of the brain and CNS including amygdala, caudate, corpus callosum, hippocampus, substantia nigra and subthalamic nucleus. Isoform 1 is the predominant isoform in monocytes, macrophages and neutrophils, isoform 2 is most strongly expressed in peripheral blood leukocytes and quiescent CD34 positive cells, and isoform 3 is expressed at low levels in all hematopoietic cell types. Expression is frequently reduced in non-small-cell lung carcinomas (NSCLC) due to hemizygous gene deletion, strongly suggesting that this locus is haploinsufficient for tumor suppression. Loss of this locus frequently occurs in tumors which retain wild-type CDKN2A/ARF and p53/TP53 loci. Hemizygous gene deletion has also been observed in leukemic blasts from patients with abnormalities of the long arm of chromosome 7.

联系我们

联系人:王羽

点击查看联系方式

企业档案

  • 会员类型:免费会员
  • 工商认证: 【未认证】
  • 最后认证时间:
  • 法人:
  • 注册号:****
  • 企业类型:生产商
  • 注册资金:人民币**万

script>
在线咨询

提交